TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25539560

Group type: EXPERIMENTAL
Intervention: Conservative therapy before arthroscopic subacromial decompression
Number of subjects: 68

Group type: COMPARATOR
Intervention: No conservative therapy before arthroscopic subacromial decompression
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Conservative therapy before surgery
Number of subjects: 68

Group type: COMPARATOR
Intervention: No conservative therapy before surgery
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups after surgery
Number of subjects: 68
Study: 22538137

Group type: EXPERIMENTAL
Intervention: Postprandial self‐monitoring of blood glucose (pp‐SMBG) at least two times a day and dietary modification based on glucose readings
Number of subjects: 169

Group type: COMPARATOR
Intervention: Dietary modification based on glucose readings but no mandatory pp‐SMBG
Number of subjects: 169
Study: 20392615

Group type: EXPERIMENTAL
Intervention: Risk factor modulation interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 18286187

Group type: EXPERIMENTAL
Intervention: Methylene blue combined with artesunate (MB-AS)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Methylene blue combined with amodiaquine (MB-AQ)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Artesunate combined with amodiaquine (AS-AQ)
Number of subjects: 180
Study: 15805993

Group type: EXPERIMENTAL
Intervention: Fluticasone (200 microg twice daily for 1 week)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Budesonide (200 microg twice daily for 1 week)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fluticasone and Budesonide
Number of subjects: 26
Study: 13129449

Group type: EXPERIMENTAL
Intervention: Sun-dried raisins (120 g/d)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cream of tartar (5 g/d)
Number of subjects: 13
Study: 10567179

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta-estradiol (50 microg/d) and norethisterone acetate (2.5 mg/d, orally)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 8896141

Group type: EXPERIMENTAL
Intervention: Treatment for depression prevention, specific details not provided.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group, specific details not provided.
Number of subjects: 0
Study: 2061443

Group type: EXPERIMENTAL
Intervention: Ro 14‐9706 (0.05% cream) applied twice daily for 16 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Tretinoin (0.05% cream) applied twice daily for 16 weeks
Number of subjects: 25
Study: 6166458

Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30786738

Group type: EXPERIMENTAL
Intervention: Regulation-Focused Psychotherapy for Children (RFP-C)
Number of subjects: 3
Study: 28839984

Group type: EXPERIMENTAL
Intervention: BC1036
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study: 25636235

Group type: EXPERIMENTAL
Intervention: vodka/orange juice (20 g alcohol)
Number of subjects: 24

Group type: COMPARATOR
Intervention: orange juice only
Number of subjects: 24
Study: 24627331

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 12944

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12944
Study: 18957387

Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg and Atenolol 50 mg (combination)
Number of subjects: 694
Study: 15218694

Group type: EXPERIMENTAL
Intervention: Smoking (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Smoking and Alcohol (Group 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (Group 1)
Number of subjects: 60
Study: 11742270

Group type: EXPERIMENTAL
Intervention: Cetirizine (0.25 mg/kg body weight administered twice daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9408935

Group type: EXPERIMENTAL
Intervention: Interferential currents (IFC) applied for 30 minutes per day for 10 days at a beat frequency of 10-25 Hz
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo group with suction electrodes applied, producing a rhythmical massage effect
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 227
Study: 8214700

Group type: EXPERIMENTAL
Intervention: Sevoflurane (slow washout)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Isoflurane (slow washout)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sevoflurane (fast washout)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Isoflurane (fast washout)
Number of subjects: 49
Study: 3321892

Group type: EXPERIMENTAL
Intervention: lidocaine/prilocaine mixture (5 g applied 90 min before testing)
Number of subjects: 116

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 116
Study: 11593305

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 27
Study: 30870668

Group type: EXPERIMENTAL
Intervention: Economic strengthening intervention
Number of subjects: 1410
Study: 29542045

Group type: EXPERIMENTAL
Intervention: Short-pulse PASCAL-PRP treatment (SP)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional PRP treatment (TP)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both SP and TP groups
Number of subjects: 52
Study: 27595676

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single photon emission computed tomography myocardial perfusion imaging (SPECT MPI)
Number of subjects: 0
Study: 24493478

Group type: EXPERIMENTAL
Intervention: Theory-based cognitive behavioral intervention (3 sessions based on IMB model)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (educational pamphlets)
Number of subjects: 176
Study: 23135194

Group type: EXPERIMENTAL
Intervention: Supra- and subgingival scaling
Number of subjects: 100

Group type: COMPARATOR
Intervention: Incision and drainage
Number of subjects: 100
Study: 19779715

Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 + IFN (arm A, suspension)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Chronic maintenance of low-dose IL-2 + IFN (arm B, maintenance)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Chemotherapy after first progression
Number of subjects: 183

Group type: COMPARATOR
Intervention: Performance Status = 0
Number of subjects: 183

Group type: COMPARATOR
Intervention: Female gender
Number of subjects: 183

Group type: COMPARATOR
Intervention: Treatment arm
Number of subjects: 183
Study: 21352119

Group type: EXPERIMENTAL
Intervention: Brief ED‐MHL intervention (information about efficacious treatments, reputable self‐help books, and further information/services)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (information about local mental health services only)
Number of subjects: 122
Study: 16244021

Group type: EXPERIMENTAL
Intervention: Plethysmographic pulse wave amplitude (PPWA) with 15 microg of epinephrine IV
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Heart rate (HR) criterion with 15 microg of epinephrine IV
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) criterion with 15 microg of epinephrine IV
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline IV (3 mL)
Number of subjects: 80
Study: 11857606

Group type: EXPERIMENTAL
Intervention: SRP/L (scaling/root planing combined with laser application)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: SRP (scaling/root planing)
Number of subjects: 10

Group type: COMPARATOR
Intervention: L (laser application)
Number of subjects: 10

Group type: COMPARATOR
Intervention: OHI (oral hygiene instructions)
Number of subjects: 10
Study: 10100441

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 119
Study: 7538285

Group type: EXPERIMENTAL
Intervention: Iloprost (50-150 micrograms orally administered twice a day for 10 days)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 2184994

Group type: EXPERIMENTAL
Intervention: Caffeine 3.5 mg/kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Caffeine 7 mg/kg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 36048

Group type: EXPERIMENTAL
Intervention: Hypertonic lactated saline (HLS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactated Ringer's solution (LRS)
Number of subjects: 0
Study: 31154565

Group type: EXPERIMENTAL
Intervention: Steroid-containing mouthwash
Number of subjects: 29
Study: 26694786

Group type: EXPERIMENTAL
Intervention: Miswak extract‐containing toothpaste (M‐group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Herbal toothpaste (P‐group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional toothpaste (C‐group)
Number of subjects: 66
Study: 26012258

Group type: EXPERIMENTAL
Intervention: Polysaccharide-rich extract of Acanthopanax senticosus (PEA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23859996

Group type: EXPERIMENTAL
Intervention: Paleo diet
Number of subjects: 13

Group type: COMPARATOR
Intervention: American Diabetes Association (ADA) diet
Number of subjects: 13
Study: 22040398

Group type: EXPERIMENTAL
Intervention: Traditional health promotion intervention
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Activated consumer intervention
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Traditional health coaching
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Activated consumer coaching
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Traditional health coaching and Activated consumer coaching
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Consumer activation coaching
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (personal development intervention)
Number of subjects: 320
Study: 19135111

Group type: EXPERIMENTAL
Intervention: Smart Bodies program
Number of subjects: 560

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 560
Study: 17762363

Group type: COMPARATOR
Intervention: NOHV (no prior hyperventilation)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HV3% (hyperventilation to an end-tidal CO2 of 3%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HV2% (hyperventilation to an end-tidal CO2 of 2%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All conditions during standing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: HV2% compared to NOHV and HV3%
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Prior hyperventilation
Number of subjects: 10
Study: 15129391

Group type: EXPERIMENTAL
Intervention: Intramuscular NMES
Number of subjects: 61
Study: 11489239

Group type: EXPERIMENTAL
Intervention: Economic analyses in randomized, controlled trials (RCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Economic analyses in large trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost‐effectiveness and cost‐utility ratios
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality‐adjusted life year
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost‐minimization, cost‐effectiveness, and cost‐utility analyses
Number of subjects: 0
Study: 9580374

Group type: EXPERIMENTAL
Intervention: Preservative-free lidocaine 1%
Number of subjects: 59

Group type: COMPARATOR
Intervention: Local-regional anesthesia (Control)
Number of subjects: 59
Study: 7761014

Group type: EXPERIMENTAL
Intervention: Room air (group I)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Supplementary oxygen (group II)
Number of subjects: 89
Study: 3193518

Group type: EXPERIMENTAL
Intervention: Castor oil
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: X-ray preparation
Number of subjects: 107

Group type: COMPARATOR
Intervention: Clear fluids 24 hours before the study
Number of subjects: 107
Study: 29294078

Group type: EXPERIMENTAL
Intervention: Acupuncture and exercises
Number of subjects: 172

Group type: COMPARATOR
Intervention: Exercises alone
Number of subjects: 172
Study: 28467572

Group type: EXPERIMENTAL
Intervention: Deep dry needling (DDN)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Peppering
Number of subjects: 72
Study: 26213579

Group type: EXPERIMENTAL
Intervention: Souvenaid (active product)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Souvenaid (active product) during the 24-week OLE
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Souvenaid (active product) continued for 24 weeks
Number of subjects: 212
Study: 24147543

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid photodynamic therapy (PDT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination therapy (PDT + imiquimod)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PDT or imiquimod therapy (second course)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 40
Study: 20376075

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg
Number of subjects: 141

Group type: COMPARATOR
Intervention: Irbesartan 300 mg
Number of subjects: 141
Study: 18771636

Group type: EXPERIMENTAL
Intervention: 2-day famciclovir (500 mg statim, then 250 mg twice daily)
Number of subjects: 873

Group type: COMPARATOR
Intervention: 5-day famciclovir (125 mg twice daily)
Number of subjects: 873

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 873
Study: 16541651

Group type: EXPERIMENTAL
Intervention: SRP plus minocycline (SRP+M)
Number of subjects: 64

Group type: COMPARATOR
Intervention: SRP (control group)
Number of subjects: 64
Study: 14651726

Group type: EXPERIMENTAL
Intervention: Cysteamine bitartrate
Number of subjects: 11
Study: 10975175

Group type: EXPERIMENTAL
Intervention: Cross-trained (CT) teams
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Reconfigured teams
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control teams
Number of subjects: 3
Study: 9327810

Group type: EXPERIMENTAL
Intervention: Predetermined payment rates based on inflation-adjusted cost per visit
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional cost reimbursement method
Number of subjects: 47
Study: 8129555

Group type: EXPERIMENTAL
Intervention: Myoglobin (MG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CPK and CPK-MM isoforms
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: MM3/MM1 > 0.5
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CPK
Number of subjects: 30
Study: 2985353

Group type: EXPERIMENTAL
Intervention: Low bulk dietary supplement
Number of subjects: 127

Group type: COMPARATOR
Intervention: High bulk dietary supplement
Number of subjects: 127

Group type: COMPARATOR
Intervention: Zinc supplement
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 30635932

Group type: EXPERIMENTAL
Intervention: Double-layer inverting closure with barbed suture
Number of subjects: 48

Group type: COMPARATOR
Intervention: Single-layer appositional closure with barbed suture
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Double-layer inverting closure with nonbarbed suture
Number of subjects: 48

Group type: COMPARATOR
Intervention: Single-layer appositional closure with nonbarbed suture
Number of subjects: 48
Study: 29099344

Group type: EXPERIMENTAL
Intervention: Tezacaftor (100 mg once daily) and Ivacaftor (150 mg twice daily)
Number of subjects: 510

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 510
Study: 26352221

Group type: EXPERIMENTAL
Intervention: ADAPT (Acceptance-based depression and psychosis therapy) for 4 months of outpatient treatment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Medication treatment as usual plus enhanced assessment and monitoring
Number of subjects: 13
Study: 23637743

Group type: EXPERIMENTAL
Intervention: Higher educational level (university vs. less than primary school)
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Physical activity (3rd vs. 1st tertile)
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Former smoking
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Larger waist‐to‐height ratio (0.1 units increase)
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Being diabetic
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Being single
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Being divorced or separated
Number of subjects: 7305

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 7305
Study: 21470746

Group type: EXPERIMENTAL
Intervention: Maxillomandibular fixation screws
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erich arch bars
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MMF screws
Number of subjects: 0
Study: 18562411

Group type: EXPERIMENTAL
Intervention: Amisulpride therapy
Number of subjects: 395
Study: 17596167

Group type: EXPERIMENTAL
Intervention: becocalcidiol 75 microg g(‐1) twice daily for 8 weeks
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: becocalcidiol 75 microg g(‐1) once daily for 8 weeks
Number of subjects: 185

Group type: COMPARATOR
Intervention: vehicle (placebo)
Number of subjects: 185
Study: 14525752

Group type: EXPERIMENTAL
Intervention: Test Group (TG) - students directed to see patients with specific chief complaints (CC): orthopedic injury (OR), asthma exacerbation (AE), acute coronary syndrome (ACS), traumatic injury (TR), laceration (LAC), diabetic ketoacidosis (DKA).
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control Group (CG) - students saw patients of their choice.
Number of subjects: 150
Study: 10461500

Group type: EXPERIMENTAL
Intervention: Radiosurgery
Number of subjects: 200000

Group type: EXPERIMENTAL
Intervention: Aggressive local therapy (surgery or radiosurgery)
Number of subjects: 200000
Study: 8877267

Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting‐Patch Trial (CABG‐Patch)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multicenter Automatic Implantable Defibrillator Trial (MADIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multicenter Unsustained Tachycardia Trial (MUSTT)
Number of subjects: 0
Study: 1830104

Group type: EXPERIMENTAL
Intervention: Hulka‐Clemens clip (spring-loaded clip)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Falope Ring (tubal ring)
Number of subjects: 365
Study: 6604723

Group type: EXPERIMENTAL
Intervention: 1 g mezlocillin intramuscularly
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 2 g mezlocillin intramuscularly
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 36
Study: 4024002

Group type: EXPERIMENTAL
Intervention: Oral high frequency oscillation (RMS input pressure 1.2 cm H2O, mean pressure zero) applied for 30 minutes alternating with 30 minutes of rest
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Oral high frequency oscillation
Number of subjects: 7
Study: 30312414

Group type: EXPERIMENTAL
Intervention: Vedolizumab
Number of subjects: 114071
Study: 27280372

Group type: COMPARATOR
Intervention: No-questionnaire control (NQC) arm
Number of subjects: 14109

Group type: EXPERIMENTAL
Intervention: Anticipated regret (AR) arm
Number of subjects: 14109
Study: 24916483

Group type: EXPERIMENTAL
Intervention: Polymyxin B (PMX) hemoperfusion, two sessions 24 hours apart
Number of subjects: 650

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 650
Study: 22811471

Group type: EXPERIMENTAL
Intervention: 1-h rhLH pulses
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 2-h rhLH pulses
Number of subjects: 19

Group type: COMPARATOR
Intervention: Continuous rhLH
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline delivery
Number of subjects: 19
Study: 20538225

Group type: EXPERIMENTAL
Intervention: Frequency specific microcurrent therapy (20 min stimulation)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham therapy (control leg)
Number of subjects: 35
Study: 19000394

Group type: EXPERIMENTAL
Intervention: Early MRI
Number of subjects: 533

Group type: COMPARATOR
Intervention: Referral to an orthopaedic specialist without prior MRI
Number of subjects: 533
Study: 15705367

Group type: EXPERIMENTAL
Intervention: rLH 37.5 IU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rLH 75 IU
Number of subjects: 0

Group type: COMPARATOR
Intervention: rFSH only (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: rLH supplementation (both doses)
Number of subjects: 0
Study: 12559647

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody treatment for cytomegalovirus retinitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 11789259

Group type: EXPERIMENTAL
Intervention: Yun'an Granule (YAG)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Progesterone
Number of subjects: 580

Group type: COMPARATOR
Intervention: Shoutai Pill
Number of subjects: 580
Study: 8997929

Group type: EXPERIMENTAL
Intervention: Treatment Counseling (TC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Symptom Monitoring (SM)
Number of subjects: 58
Study: 1376735

Group type: EXPERIMENTAL
Intervention: Chronic idiopathic urticaria (CIU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic idiopathic urticaria in remission (CIUR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal control (NC) subjects
Number of subjects: 0
Study: 6388302

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 341

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Severity of angina
Number of subjects: 341
Study: 31142269

Group type: EXPERIMENTAL
Intervention: MRSA colonization in middle/low SES (n = 18; 14%)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: MRSA strains susceptibility
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: SCCmec types
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: MRSA isolates carrying PVL genes
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: BHS carriers
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: BHS susceptibility
Number of subjects: 598
Study: 29501977

Group type: EXPERIMENTAL
Intervention: Panitumumab with standard epirubicin, cisplatin, capecitabine (ECX) chemotherapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard epirubicin, cisplatin, capecitabine (ECX) chemotherapy without panitumumab
Number of subjects: 160
Study: 26971236

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg
Number of subjects: 201

Group type: COMPARATOR
Intervention: Clopidogrel 300 mg
Number of subjects: 201